Laurus Labs Limited vs Veerhealth Care Ltd

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Veerhealth Care Ltd (VEERHEALTHCARELTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads LAURUSLABS vs VEERHEALTHCARELTD on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
64.90
19.74
P/B ratio
4.36
0.10%
Dividend yield
0.00%
₹16.47
EPS
₹0.20

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
2.97%
17.58%
Return on capital
3.14%
26.09%
EBITDA margin
2.76%
13.07%
Net margin
2.34%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
34.73%
3.91%
Profit CAGR (3Y)
-13.01%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹102 Cr
₹6,813 Cr
Revenue
₹17 Cr
₹890 Cr
Net profit
₹0 Cr
0.45
Debt / equity
0.20
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Veerhealth Care Ltd
  • + ["Company is expected to give good quarter", "Company's working capital requirements have reduced from 158 days to 51.4 days"]
  • − ["Stock is trading at 4.42 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 31.9%", "Company has a low return on equity of 2.22% over last 3 years."]
Laurus Labs Limited full analysis Veerhealth Care Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.